Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 195

    1.

    NIH Conference. Alzheimer's disease and Down's syndrome: new insights.

    Cutler NR, Heston LL, Davies P, Haxby JV, Schapiro MB.

    Ann Intern Med. 1985 Oct;103(4):566-78. Review.PMID: 2864010 [PubMed - indexed for MEDLINE]Related articles

    2.

    Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.

    Pietrini P, Dani A, Furey ML, Alexander GE, Freo U, Grady CL, Mentis MJ, Mangot D, Simon EW, Horwitz B, Haxby JV, Schapiro MB.

    Am J Psychiatry. 1997 Aug;154(8):1063-9.PMID: 9247390 [PubMed - indexed for MEDLINE]Related articles

    3.

    Decline in cerebral glucose utilisation and cognitive function with aging in Down's syndrome.

    Schapiro MB, Haxby JV, Grady CL, Duara R, Schlageter NL, White B, Moore A, Sundaram M, Larson SM, Rapoport SI.

    J Neurol Neurosurg Psychiatry. 1987 Jun;50(6):766-74.PMID: 2956363 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cerebral metabolism as measured with positron emission tomography (PET) and [18F] 2-deoxy-D-glucose: healthy aging, Alzheimer's disease and Down syndrome.

    Cutler NR.

    Prog Neuropsychopharmacol Biol Psychiatry. 1986;10(3-5):309-21.PMID: 2948218 [PubMed - indexed for MEDLINE]Related articles

    5.

    NIH Conference. Brain imaging: aging and dementia.

    Cutler NR, Duara R, Creasey H, Grady CL, Haxby JV, Schapiro MB, Rapoport SI.

    Ann Intern Med. 1984 Sep;101(3):355-69.PMID: 6235763 [PubMed - indexed for MEDLINE]Related articles

    6.

    High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study.

    Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB.

    Am J Psychiatry. 1999 Dec;156(12):1879-86.PMID: 10588400 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Relation of medial temporal lobe volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease.

    Krasuski JS, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB.

    Am J Psychiatry. 2002 Jan;159(1):74-81.PMID: 11772693 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

    Rumble B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, Hockey A, Montgomery P, Beyreuther K, Masters CL.

    N Engl J Med. 1989 Jun 1;320(22):1446-52.PMID: 2566117 [PubMed - indexed for MEDLINE]Related articles

    9.

    Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry.

    Teipel SJ, Alexander GE, Schapiro MB, Möller HJ, Rapoport SI, Hampel H.

    Brain. 2004 Apr;127(Pt 4):811-24. Epub 2004 Feb 25.PMID: 14985261 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Quantitative regional analysis and comparison with Alzheimer's disease.

    Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH.

    Arch Neurol. 1995 Apr;52(4):379-91.PMID: 7710374 [PubMed - indexed for MEDLINE]Related articles

    11.

    Brain metabolism as measured with positron emission tomography: serial assessment in a patient with familial Alzheimer's disease.

    Cutler NR, Haxby JV, Duara R, Grady CL, Moore AM, Parisi JE, White J, Heston L, Margolin RM, Rapoport SI.

    Neurology. 1985 Nov;35(11):1556-61.PMID: 3877253 [PubMed - indexed for MEDLINE]Related articles

    12.

    APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome.

    Deb S, Braganza J, Norton N, Williams H, Kehoe PG, Williams J, Owen MJ.

    Br J Psychiatry. 2000 May;176:468-72.PMID: 10912224 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Down's syndrome and Alzheimer's dementia: defining an association.

    Heston LL.

    Psychiatr Dev. 1984 Winter;2(4):287-94. Review.PMID: 6241313 [PubMed - indexed for MEDLINE]Related articles

    14.

    Relation of EEG alpha background to cognitive function, brain atrophy, and cerebral metabolism in Down's syndrome. Age-specific changes.

    Devinsky O, Sato S, Conwit RA, Schapiro MB.

    Arch Neurol. 1990 Jan;47(1):58-62.PMID: 2136791 [PubMed - indexed for MEDLINE]Related articles

    15.

    Preferential metabolic involvement of visual cortical areas in a subtype of Alzheimer's disease: clinical implications.

    Pietrini P, Furey ML, Graff-Radford N, Freo U, Alexander GE, Grady CL, Dani A, Mentis MJ, Schapiro MB.

    Am J Psychiatry. 1996 Oct;153(10):1261-8.PMID: 8831432 [PubMed - indexed for MEDLINE]Related articles

    16.

    Alzheimer's disease in Down's syndrome. A review.

    Karlinsky H.

    J Am Geriatr Soc. 1986 Oct;34(10):728-34. Review.PMID: 2944942 [PubMed - indexed for MEDLINE]Related articles

    17.

    A four year prospective study of age-related cognitive change in adults with Down's syndrome.

    Oliver C, Crayton L, Holland A, Hall S, Bradbury J.

    Psychol Med. 1998 Nov;28(6):1365-77.PMID: 9854278 [PubMed - indexed for MEDLINE]Related articles

    19.

    Levels of phospholipid catabolic intermediates, glycerophosphocholine and glycerophosphoethanolamine, are elevated in brains of Alzheimer's disease but not of Down's syndrome patients.

    Blusztajn JK, Lopez Gonzalez-Coviella I, Logue M, Growdon JH, Wurtman RJ.

    Brain Res. 1990 Dec 17;536(1-2):240-4.PMID: 2150771 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Down's syndrome and dementia]

    Parajuá-Pozo JL, Casis-Arguea S.

    Rev Neurol. 2000 Jul 16-31;31(2):126-8. Spanish. PMID: 10951667 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data